A well-known peptide in growth-hormone research.
For Research Use Only
CJC-1295 (no DAC) / Ipamorelin
A two-part growth-hormone secretagogue blend pairing a GHRH analog with a selective ghrelin-receptor pentapeptide, supplied for research use only.
Blend composition
- CJC-1295 (no DAC)5mg
- Ipamorelin5mg
Certificate of analysis on this page
Fast, tracked shipping
Research overview
This blend combines two synthetic growth-hormone secretagogues supplied together as a research reference standard: CJC-1295 without DAC — also known as Modified GRF (1-29) or Mod GRF (1-29), a tetrasubstituted 29-amino-acid analog of growth hormone-releasing hormone (GHRH 1-29) — and Ipamorelin, a selective pentapeptide agonist of the ghrelin / growth hormone secretagogue receptor (GHS-R1a).
The two components appear in the growth-hormone-axis literature acting on complementary pathways, where the GHRH-analog and ghrelin-receptor-agonist mechanisms are studied together in animal and cell models. Supplied lyophilized; for laboratory research use only.
Also known as: CJC-1295 without DAC, Modified GRF (1-29), Mod GRF 1-29, Ipamorelin, Mod GRF 1-29 + Ipamorelin
Lot 0420199 · ≥99.0% HPLC
Research areas
- Growth-hormone secretagogue signalling
- GHRH-receptor pharmacology
- Ghrelin-receptor (GHS-R1a) models
Documentation
Certificates of analysis
Every lot is third-party tested by HPLC and mass spectrometry. View the certificate for the current lot, or pull the COA for an earlier lot you may already have on the bench.
Each certificate reports HPLC purity, mass-spectrometry identity, appearance, and net peptide content for that specific lot.
Related research standards
A growth-hormone-releasing-factor analog used in endocrine research.
For Research Use OnlyA copper peptide studied in hair-follicle, angiogenesis, and skin-research models.
For Research Use Only